Al-Dawaa' shares bounce back to 32.72 riyals

The stock of Saudi Pharmaceutical Industries and Medical Supplies Company "Dawaa" increased after managing to rebound from the upward trend line since June, accompanied by a rise in trading volumes. Currently, it faces resistance at 32.72 SAR, which is an important point to confirm the continuation of its upward trend. If the stock succeeds in surpassing this level supported by strong trading momentum, it is expected to continue its rise toward 33.24 SAR and then 34.34 SAR. The primary support level remains at 30.70 SAR; maintaining this level is crucial for the sustainability of the bullish outlook, with close attention to trading volumes, as they are a key confirming factor for the next move.

articleDetails.fontSize.sizeحجم النص

تنويه: هذا ملخص تم إنشاؤه بواسطة الذكاء الاصطناعي

عرض المقال بالكامل